What top creators are saying about Cogent Biosciences, Inc.(COGT)
Biotech company with data for gastrointestinal stromal tumors
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Cogent Biosciences, Inc. in the last 30 days yet.
Top creators covering Cogent Biosciences, Inc. (COGT)
The 1 sources with the most insights about Cogent Biosciences, Inc. on Kazuha.
Latest insights about Cogent Biosciences, Inc. (COGT)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, November 10, 2025
The company reported "good data" and "seems like a buy still," but the speaker is uncertain about its commercial potential and ultimately passed on the trade.
Monday, November 10, 2025
The company reported "good data" and "seems like a buy still," but the speaker is uncertain about its commercial potential and ultimately passed on the trade.
Discussed alongside Cogent Biosciences, Inc. (COGT)
Other assets that creators frequently mention in the same content as Cogent Biosciences, Inc..
Frequently asked
Which podcasters and creators cover Cogent Biosciences, Inc. (COGT) the most?
The most active sources covering Cogent Biosciences, Inc. (COGT) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Cogent Biosciences, Inc. (COGT) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Cogent Biosciences, Inc. (COGT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Cogent Biosciences, Inc. (COGT)?
Creators covering Cogent Biosciences, Inc. (COGT) most frequently also discuss QUBT, NVDA, IFRX, GLTO, PLTR. See the "Discussed alongside" section above for full asset pages.